Developments in evidence creation for treatments of inborn errors of metabolism.


Journal

Journal of inherited metabolic disease
ISSN: 1573-2665
Titre abrégé: J Inherit Metab Dis
Pays: United States
ID NLM: 7910918

Informations de publication

Date de publication:
01 2021
Historique:
received: 28 09 2018
revised: 13 09 2020
accepted: 14 09 2020
pubmed: 19 9 2020
medline: 24 12 2021
entrez: 18 9 2020
Statut: ppublish

Résumé

Inborn errors of metabolism (IEM) represent the first group of genetic disorders, amenable to causal therapies. In addition to traditional medical diet and cofactor treatments, new treatment strategies such as enzyme replacement and small molecule therapies, solid organ transplantation, and cell-and gene-based therapies have become available. Inherent to the rare nature of the single conditions, generating high-quality evidence for these treatments in clinical trials and under real-world conditions has been challenging. Guidelines developed with standardized methodologies have contributed to improve the practice of care and long-term clinical outcomes. Adaptive trial designs allow for changes in sample size, group allocation and trial duration as the trial proceeds. n-of-1 studies may be used in small sample sized when participants are clinically heterogeneous. Multicenter observational and registry-based clinical trials are promoted via international research networks. Core outcome and standard data element sets will enhance comparative analysis of clinical trials and observational studies. Patient-centered outcome-research as well as patient-led research initiatives will further accelerate the development of therapies for IEM.

Identifiants

pubmed: 32944978
doi: 10.1002/jimd.12315
pmc: PMC7891579
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-98

Subventions

Organisme : CIHR
ID : TR3-119195
Pays : Canada

Informations de copyright

© 2020 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.

Références

Sci Transl Med. 2016 Sep 7;8(355):355ra118
pubmed: 27605553
J Inherit Metab Dis. 2003;26(2-3):181-8
pubmed: 12889659
Value Health. 2017 Jul - Aug;20(7):838-855
pubmed: 28712612
Mol Genet Metab Rep. 2018 Jul 20;16:57-63
pubmed: 30094186
Trials. 2017 Dec 19;18(1):603
pubmed: 29258568
Trials. 2012 Aug 06;13:132
pubmed: 22867278
Psychol Methods. 2012 Dec;17(4):510-50
pubmed: 22845874
Orphanet J Rare Dis. 2011 Apr 16;6:16
pubmed: 21496291
Mol Genet Metab. 2016 Jun;118(2):65-9
pubmed: 27132782
Mol Genet Metab. 2014 Jul;112(3):210-7
pubmed: 24881969
Mol Genet Metab. 2017 Jun;121(2):70-79
pubmed: 28501294
Orphanet J Rare Dis. 2017 Nov 2;12(1):171
pubmed: 29096663
Stat Methods Med Res. 2020 Jun;29(6):1483-1498
pubmed: 31354106
Arch Public Health. 2014 Oct 13;72(1):35
pubmed: 25352985
Genet Med. 2013 Jun;15(6):415-22
pubmed: 23222662
Genet Med. 2017 Dec;19(12):
pubmed: 28771246
J Inherit Metab Dis. 2017 Jan;40(1):75-101
pubmed: 27853989
Orphanet J Rare Dis. 2020 Jan 14;15(1):12
pubmed: 31937333
J Inherit Metab Dis. 2017 Jan;40(1):21-48
pubmed: 27905001
Mol Genet Metab. 2012 Mar;105(3):368-81
pubmed: 22212131
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Clin Pharmacol Ther. 2015 Mar;97(3):234-46
pubmed: 25669457
Arch Dis Child. 2013 Jun;98(6):454-61
pubmed: 23532493
Neurotherapeutics. 2013 Oct;10(4):688-97
pubmed: 24048860
Health Aff (Millwood). 2014 Jul;33(7):1212-9
pubmed: 25006148
Drug Discov Today. 2018 Jun;23(6):1251-1257
pubmed: 29455022
Mol Genet Metab. 2019 Apr;126(4):341-354
pubmed: 30879957
Genet Med. 2016 Feb;18(2):117-23
pubmed: 25856667
J Clin Epidemiol. 2016 Aug;76:18-46
pubmed: 26272791
Mol Genet Metab. 2015 Sep-Oct;116(1-2):35-43
pubmed: 26026794
Genet Med. 2014 Feb;16(2):188-200
pubmed: 24385074
Genet Med. 2014 Nov;16(11):e1
pubmed: 25356975
Contemp Clin Trials. 2012 Jul;33(4):647-56
pubmed: 22405970
N Engl J Med. 2019 Oct 24;381(17):1644-1652
pubmed: 31597037
J Am Med Inform Assoc. 2015 Jan;22(1):76-85
pubmed: 25038198
Int J Appl Basic Med Res. 2012 Jan;2(1):3-6
pubmed: 23776799
CMAJ. 2010 Dec 14;182(18):E839-42
pubmed: 20603348
Ann Neurol. 2010 Nov;68(5):743-52
pubmed: 21031586
Patient Prefer Adherence. 2017 Sep 13;11:1573-1583
pubmed: 28979105
Mol Genet Metab. 2012 Nov;107(3):335-44
pubmed: 23022070
BMJ. 2018 Jul 25;362:k3193
pubmed: 30045909
BMJ. 2001 Aug 11;323(7308):334-6
pubmed: 11498496
Lancet Neurol. 2007 Sep;6(9):765-72
pubmed: 17689147
Orphanet J Rare Dis. 2015 Dec 30;10:164
pubmed: 26714856
Mol Genet Metab. 2008 Apr;93(4):363-70
pubmed: 18155630
J Clin Epidemiol. 2010 Dec;63(12):1312-23
pubmed: 20863658
Contemp Clin Trials. 2015 May;42:78-80
pubmed: 25797358
Orphanet J Rare Dis. 2020 May 26;15(1):126
pubmed: 32456656
Mol Genet Metab. 2013 Jan;108(1):85-9
pubmed: 23266197
Mol Genet Metab. 2014 Sep-Oct;113(1-2):105-8
pubmed: 25261246
Orphanet J Rare Dis. 2013 Mar 25;8:48
pubmed: 23531234
Orphanet J Rare Dis. 2016 May 18;11(1):66
pubmed: 27194034
Orphanet J Rare Dis. 2019 Jan 8;14(1):7
pubmed: 30621767
Nat Med. 2006 Mar;12(3):307-9
pubmed: 16491085
Trials. 2014 Jun 25;15:247
pubmed: 24962012
BMC Med Ethics. 2018 Mar 7;19(1):21
pubmed: 29514618
Orphanet J Rare Dis. 2018 Jun 28;13(1):104
pubmed: 29954425
Nucleic Acids Res. 2017 Jan 4;45(D1):D865-D876
pubmed: 27899602
Orphanet J Rare Dis. 2017 Jan 18;12(1):12
pubmed: 28100251
Stat Med. 2014 Oct 30;33(24):4186-201
pubmed: 24957522
Orphanet J Rare Dis. 2014 Jan 13;9:7
pubmed: 24422943
N Engl J Med. 2013 Oct 24;369(17):1579-81
pubmed: 23991657
Genet Med. 2019 Apr;21(4):772-789
pubmed: 30659246
Annu Rev Med. 2015;66:471-86
pubmed: 25587658
Mol Genet Metab. 2018 Apr;123(4):488-494
pubmed: 29478819
J Inherit Metab Dis. 2008 Oct;31(5):580-98
pubmed: 18850300
J Inherit Metab Dis. 2010 Oct;33(5):555-61
pubmed: 20830526
J Clin Epidemiol. 2016 Aug;76:9-17
pubmed: 26272792
J Inherit Metab Dis. 2012 Jan;35(1):115-23
pubmed: 21630065
J Inherit Metab Dis. 2021 Jan;44(1):88-98
pubmed: 32944978
Orphanet J Rare Dis. 2008 May 02;3:11
pubmed: 18454853
PLoS One. 2014 Jun 16;9(6):e99111
pubmed: 24932522
Stat Med. 2012 Nov 10;31(25):2973-84
pubmed: 22711298
J Eval Clin Pract. 2013 Aug;19(4):584-90
pubmed: 22168925
J Inherit Metab Dis. 2019 Jan;42(1):5-28
pubmed: 30740725
Int J Environ Res Public Health. 2018 Aug 03;15(8):
pubmed: 30081484
Lancet. 1953 Oct 17;265(6790):812-3
pubmed: 13098090
J Inherit Metab Dis. 2021 Jan;44(1):178-192
pubmed: 33200442
Best Pract Res Clin Rheumatol. 2014 Apr;28(2):247-62
pubmed: 24974061
Orphanet J Rare Dis. 2020 Apr 10;15(1):89
pubmed: 32276663
J Clin Epidemiol. 2011 Oct;64(10):1085-94
pubmed: 21530171
Orphanet J Rare Dis. 2017 Oct 12;12(1):162
pubmed: 29025426
Orphanet J Rare Dis. 2017 Dec 22;12(1):188
pubmed: 29273068
Mol Genet Metab. 2008 Jun;94(2):157-61
pubmed: 18343177
Mol Genet Metab. 2009 Mar;96(3):85-90
pubmed: 19157942
Orphanet J Rare Dis. 2011 Nov 30;6:79
pubmed: 22129361
J Clin Epidemiol. 2016 Dec;80:16-24
pubmed: 27555082
Mol Genet Metab. 2016 Jun;118(2):72-83
pubmed: 27211276
PLoS One. 2012;7(11):e50947
pubmed: 23226429
BMJ. 2014 Nov 24;349:g6802
pubmed: 25422272
J Inherit Metab Dis. 2011 Jun;34(3):677-94
pubmed: 21431622
Clin Pharmacol Ther. 2014 Mar;95(3):265-8
pubmed: 24193169
J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):275-8
pubmed: 16763887
J Gen Intern Med. 2014 Aug;29 Suppl 3:S801-3
pubmed: 25029974
Contemp Clin Trials. 2016 Jan;46:100-105
pubmed: 26611435
J Inherit Metab Dis. 2017 Jan;40(1):49-74
pubmed: 27778219
J Inherit Metab Dis. 2019 Nov;42(6):1192-1230
pubmed: 30982989
J Gen Intern Med. 2014 Aug;29 Suppl 3:S739-44
pubmed: 25029976
Orphanet J Rare Dis. 2014 Sep 02;9:130
pubmed: 25205257
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11601-6
pubmed: 9326656
J Inherit Metab Dis. 2017 Mar;40(2):171-176
pubmed: 27858262
Curr Top Med Chem. 2014;14(3):330-9
pubmed: 24283970
J Med Internet Res. 2017 Jun 06;19(6):e195
pubmed: 28588006
Orphanet J Rare Dis. 2012 May 29;7:32
pubmed: 22642880
Am J Med Genet A. 2017 Sep;173(9):2307-2322
pubmed: 28731526
Mitochondrion. 2013 Jan;13(1):15-24
pubmed: 23164801

Auteurs

Sylvia Stockler-Ipsiroglu (S)

Division of Biochemical Genetics, Department of Pediatrics, and BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.

Beth K Potter (BK)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

Nataliya Yuskiv (N)

Division of Biochemical Genetics, Department of Pediatrics, and BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.

Kylie Tingley (K)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

Marc Patterson (M)

Division of Child and Adolescent Neurology, Departments of Neurology Pediatrics and Medical Genetics, Mayo Clinic Children's Center, Rochester, Minnesota, USA.

Clara van Karnebeek (C)

Departments of Pediatrics and Clinical Genetics, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Department of Pediatrics, Radboud University Medical Centre, Nijmegen, The Netherlands.
Department of Pediatrics, BC Children's Hospital Research Institute, Centre for Molecular Medicine and Therapeutics, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH